LataMed AI is trading at $0.30, down 14.38%, amid broad risk-off conditions.

  • The move extends recent weakness from September 14 and September 11; no company-specific announcement dated September 15 explains the decline.
  • The latest disclosed agreement, published September 9, concerns planned Venezuelan healthcare-technology deployment and reports no resulting revenue or financial performance.
  • Major U.S. indexes are down more than 0.5%, with elevated Treasury yields, higher oil prices and Federal Reserve policy uncertainty; LataMed AI is trading during the open session, with no company-specific volume available.